TMO
Thermo Fisher Scientific Inc · Healthcare · Diagnostics & Research
TECHBuyZACKSBuy
R500#221 today
$654.80
+0.35% today · -2.99% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- TMO +0.35% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 63 big drops in the past 5 years, TMO typically gained 0.3% over the next day (median) and was higher 57% of the time; half the outcomes fell between -0.9% and +1.5%. An ordinary day: -0.0%. Among S&P 500 stocks after big drops, that ranks #102 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 21
Before the open · in 17 days
EPS estimate
$6.41
$6.33 to $6.56 · 21 analysts
Revenue estimate
$11.9B
$11.8B to $12.1B
Track record
8/8 beats
last 8 reports · moved ±5.1% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 BMO | 2Q2026 | $5.71 | $6.03 | +$0.32 (+5.6%) beat | $12.0B | +8.7% +9.9 vs SPY | +9.0% | +9.5% |
| Apr 23, 2026 BMO | 1Q2026 | $5.24 | $5.44 | +$0.20 (+3.8%) beat | $11.0B | -9.2% -8.8 vs SPY | -8.0% | -9.3% |
| Jan 29, 2026 BMO | 4Q2025 | $6.45 | $6.57 | +$0.12 (+1.9%) beat | $12.2B | -2.6% -2.4 vs SPY | -3.6% | -7.0% |
| Oct 22, 2025 BMO | 3Q2025 | $5.50 | $5.79 | +$0.29 (+5.3%) beat | $11.1B | +1.6% +2.2 vs SPY | -0.5% | -0.1% |
| Jul 23, 2025 BMO | $5.23 | $5.36 | +$0.13 (+2.5%) beat | — | +9.1% +8.3 vs SPY | +10.7% | +12.8% | |
| Apr 23, 2025 BMO | $5.10 | $5.15 | +$0.05 (+1.0%) beat | — | -0.7% -2.3 vs SPY | +5.0% | -1.7% | |
| Jan 30, 2025 BMO | $5.94 | $6.10 | +$0.16 (+2.7%) beat | — | +6.8% +6.2 vs SPY | +3.9% | +2.5% | |
| Oct 23, 2024 BMO | $5.25 | $5.28 | +$0.03 (+0.6%) beat | — | -1.7% -0.8 vs SPY | -2.0% | -6.6% | |
| Jul 24, 2024 BMO | $5.13 | $5.37 | +$0.24 (+4.7%) beat | — | +4.1% +6.3 vs SPY | +0.1% | +11.4% | |
| Apr 24, 2024 BMO | $4.71 | $5.11 | +$0.40 (+8.5%) beat | — | +0.5% +0.5 vs SPY | +0.6% | -1.0% | |
| Jan 31, 2024 BMO | $5.65 | $5.67 | +$0.02 (+0.4%) beat | — | -5.0% -3.3 vs SPY | -0.7% | -1.2% | |
| Oct 25, 2023 BMO | $5.61 | $5.69 | +$0.08 (+1.4%) beat | — | -5.5% -4.0 vs SPY | -7.7% | -2.9% | |
| Jul 26, 2023 BMO | $5.43 | $5.15 | −$0.28 (−5.2%) miss | — | +0.6% +0.6 vs SPY | -2.8% | -4.4% | |
| Apr 26, 2023 BMO | $5.03 | $5.03 | $0.00 (0.0%) in line | — | -2.8% -2.4 vs SPY | -3.7% | -0.8% | |
| Feb 1, 2023 BMO | $5.20 | $5.40 | +$0.20 (+3.8%) beat | — | +3.0% +1.9 vs SPY | +2.8% | +2.2% | |
| Oct 26, 2022 BMO | $4.82 | $5.08 | +$0.26 (+5.4%) beat | — | -2.3% -1.5 vs SPY | -2.8% | +0.6% | |
| Jul 28, 2022 BMO | $4.98 | $5.51 | +$0.53 (+10.6%) beat | — | +2.7% +1.4 vs SPY | +1.4% | +1.0% | |
| Apr 28, 2022 BMO | $6.21 | $7.25 | +$1.04 (+16.7%) beat | — | +7.4% +4.8 vs SPY | +7.5% | +8.2% | |
| Feb 2, 2022 BMO | $5.27 | $6.54 | +$1.27 (+24.1%) beat | — | +1.6% +0.7 vs SPY | +2.0% | -1.1% | |
| Oct 27, 2021 BMO | $4.70 | $5.76 | +$1.06 (+22.6%) beat | — | +0.7% +1.1 vs SPY | +1.4% | +4.6% | |
| Jul 28, 2021 BMO | $5.47 | $5.60 | +$0.13 (+2.4%) beat | — | — | — | — | |
| Apr 29, 2021 BMO | $6.68 | $7.21 | +$0.53 (+7.9%) beat | — | — | — | — | |
| Feb 1, 2021 BMO | $6.57 | $7.09 | +$0.52 (+7.9%) beat | — | — | — | — | |
| Oct 21, 2020 BMO | $4.30 | $5.63 | +$1.33 (+30.9%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $6.41 (21) | $6.33 – $6.56 | +11% | +0.7% | ▲1 ▼2 | $11.9B | +7% |
| Next quarter · Dec 31, 2026 | $7.26 (20) | $7.12 – $7.40 | +10% | -1.1% | ▲1 ▼2 | $12.9B | +6% |
| Current year · Dec 31, 2026 | $25.13 (26) | $24.98 – $25.40 | +10% | +1.1% | ▲24 ▼0 | $47.9B | +7% |
| Next year · Dec 31, 2027 | $27.55 (27) | $26.49 – $29.07 | +10% | +1.1% | ▲2 ▼1 | $50.3B | +5% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.